MorphoSys AG
PLANEGG, GERMANY and MUNICH, GERMANY / ACCESSWIRE / July 21, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR), a commercial-stage biopharmaceutical company and a leader in antibody and protein technologies, will publish its results for the second quarter and first half 2021 on July 28, 2021 at 10:00pm CEST (4:00pm EDT).
MorphoSys' Management Board will host a conference call and webcast on July 29, 2021 at 2:00pm CEST (8:00am EDT) to present the second quarter and first half financial results 2021 and provide a further outlook for 2021.
The conference call will start with a presentation by the Management Board followed by a Q&A session. Following Board Members will be on the call:
- Jean-Paul Kress, M.D., Chief Executive Officer
- Sung Lee, Chief Financial Officer
- Roland Wandeler, Ph.D., Chief Operating Officer
- Malte Peters, M.D., Chief Research & Development Officer
A live webcast and slides will be made available at the Media and Investors section under Conferences on MorphoSys' website, www.morphosys.com .
Dial-in number for the conference call (2:00pm CEST, 8:00am EDT):
Germany: +49 69 201 744 220
For UK residents: +44 203 009 2470
For US residents: +1 877 423 0830
(all numbers reachable from any geography)
Participant PIN: 72989449#
Please dial in 10 minutes before the beginning of the conference.
A replay of the conference will also be available at the corporate website following the live event.
About MorphoSys
MorphoSys (FSE:MOR)(NASDAQ:MOR) is a biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for people living with cancer and autoimmune diseases. Based on its leading expertise in antibody and protein technologies, MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. In 2017, Tremfya (R) (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys' antibody technology to receive regulatory approval. In July 2020, the U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (R) (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma. Headquartered near Munich, Germany, the MorphoSys Group, including the fully owned U.S. subsidiaries MorphoSys US Inc. and Constellation Pharmaceuticals, Inc., has more than 750 employees. For more information visit www.morphosys.com or www.morphosys-us.com .
Monjuvi (R) is a registered trademark of MorphoSys AG.
Tremfya (R) is a registered trademark of Janssen Biotech, Inc.
Forward Looking Statements
This communication contains certain forward-looking statements concerning the MorphoSys group of companies. The forward-looking statements contained herein represent the judgment of MorphoSys as of the date of this release and involve known and unknown risks and uncertainties, which might cause the actual results, financial condition and liquidity, performance or achievements of MorphoSys, or industry results, to be materially different from any historic or future results, financial conditions and liquidity, performance or achievements expressed or implied by such forward-looking statements. In addition, even if MorphoSys' results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. Among the factors that may result in differences are that MorphoSys' expectations may be incorrect, the inherent uncertainties associated with competitive developments, clinical trial and product development activities and regulatory approval requirements, MorphoSys' reliance on collaborations with third parties, estimating the commercial potential of its development programs and other risks indicated in the risk factors included in MorphoSys' Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. MorphoSys expressly disclaims any obligation to update any such forward-looking statements in this document to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements, unless specifically required by law or regulation.
For more information, please contact:
Media Contacts:
Thomas Biegi
Vice President
Tel.: +49 (0)89 / 899 27 26 079
thomas.biegi@morphosys.com
Investor Contacts:
Dr. Julia Neugebauer
Senior Director
Tel: +49 (0)89 / 899 27 179
julia.neugebauer@morphosys.com
Jeanette Bressi
Director, US Communications
Tel: +1 617 404 7816
jeanette.bressi@morphosys.com
Myles Clouston
Senior Director
Tel: +1 857 772 0240
myles.clouston@morphosys.com
SOURCE: MorphoSys AG
View source version on accesswire.com:
https://www.accesswire.com/656539/Invitation-to-MorphoSys-Second-Quarter-and-First-Half-2021-Results-Conference-Call-on-July-29-2021
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Camino Announces High-Grade Channel Results of 7 Meters @ 4.3% Copper, 25.5 ppm Silver and 18 meters @ 1.57 % Copper and 11.35 ppm Silver at Los Chapitos in Peru17.6.2025 12:00:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / June 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce high‐grade copper channel results from the Katty prospect located in the Diva Trend, one of several prospective targets at the Company's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. A total of 12 excavated channels were completed at the prospect and all channels contained significant high-grade intercepts of copper with associated silver (Table 1). Los Chapitos is Camino's second copper project with partner Nittetsu Mining Co, Ltd. ("Nittetsu"), which can earn a 35% interest in Los Chapitos once it completes a total investment of CDN$10 Million (see news release dated June 14, 2023). Rio Tinto, a major copper producer, recently staked claims adjacent to Los Chapitos (see news release dated May 17, 2024). Camino is also advancing its mine development project, the Puquios Copper Project, with Nittetsu Mining
The 12th GLA Global Logistics Conference: A New Chapter in International Logistics Cooperation17.6.2025 05:50:00 CEST | Press release
DUBAI, AE / ACCESS Newswire / June 16, 2025 / From May 15 to 18, 2025, the 12th GLA Global Logistics Conference was held at the Grand Hyatt Dubai, shaping the future of the international logistics landscape. Organized by the Global Logistics Enterprises Federation (GLEF) and the GLA Global Logistics Alliance, the conference gathered nearly 2,000 professionals, including logistics experts, senior executives and government officials from over 130 countries and regions. This year's edition reinforced GLA's position as a central hub for strategic networking, innovation and global trade cooperation. Group Photo of the 12th GLA Global Logistics Conference Under the theme "Peaceful Prosperity · Digital Innovation · Trustworthy Cooperation," the conference reflected the logistics sector's collective ambition to respond to today's challenges, ranging from geopolitical disruptions and supply chain volatility to technological advancement and environmental demands. The Opening Ceremony of the 12th
Corsair Signs Strategic Partnership with Kera Energy for Global Distribution of Pyrolysis Oil16.6.2025 09:10:00 CEST | Press release
New partnership expands global access to Corsair's recycled plastic oil across Europe, Asia, and the Americas. AMSTERDAM, NETHERLANDS / ACCESS Newswire / June 16, 2025 / Plastic waste recycling company Corsair Group International Holding BV (CORSAIR) is proud to announce a new strategic partnership with KERA Energy AG, a Swiss-based leader in sustainable industrial value chains. Under the agreement, CORSAIR will supply advanced pyrolysis oil to KERA Energy, which will distribute the Plastic Pyrolysis Oil (PPO) across key markets in Europe, Asia, and the Americas. This collaboration marks another important step in CORSAIR's mission to scale up sustainable advanced recycling of plastic waste. The agreement with KERA Energy signals growing international demand for CORSAIR's high-quality pyrolysis oil derived from everyday household plastic waste. "We are very pleased to partner with KERA Energy, a company that shares our vision of a cleaner, circular economy," said Jussi Veikko Saloranta,
GA-ASI Announces New PELE Small UAS for International Customers16.6.2025 06:00:00 CEST | Press release
Small, Uncrewed Launched Effect Delivers Multi-Mission Capability SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in unmanned aircraft from the iconic Predator® to the YFQ-42A Collaborative Combat Aircraft, has unveiled a new small uncrewed launched effect with widespread multi-mission capabilities for the global aerospace and defense market. Inspired by Pele, the Hawaiian goddess of powerful natural forces in the Pacific, the Precision Exportable Launched Effect - PELE - is a small, attrition-tolerant, propeller-driven unmanned aircraft designed to extend the sensing and other capabilities of a mothership aircraft and its user service. PELE is a semi-autonomous unmanned aircraft system (UAS) with an 11-foot wingspan and 16-horsepower engine that extends user reach within challenging environments with potent effects. PELE also could be launched from the ground. The new PELE is optimized for use on the MQ-9B SkyGuar
GA-ASI Adds Saab Airborne Early Warning Capability to MQ-9B16.6.2025 06:00:00 CEST | Press release
New Capability Will Transform Airborne Early Warning Access and Affordability for MQ-9B Customers SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is partnering with Saab to develop Airborne Early Warning and Control (AEW&C) capability for its line of MQ-9B Remotely Piloted Aircraft, which includes the SkyGuardian® and SeaGuardian® models, the United Kingdom's Protector, and the new MQ-9B STOL (Short Takeoff and Landing) model currently in development. GA-ASI plans to fly AEW on MQ-9B in 2026. "High and low-tech air threats both pose major challenges to global air forces," said GA-ASI President David R. Alexander. "We're developing an affordable AEW solution in cooperation with Saab, the leading provider of AEW&C systems, that will transform our customers' operations against both sophisticated cruise missiles and simple but dangerous drone swarms. We're also making AEW capability possible in areas it doesn't exist today, such as from
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom